|
|
Article: Danvers, Mass.-Based Abiomed Seeks Wall Street's Heart with New Device.
- Article from:
- Knight Ridder/Tribune Business News
- Article date:
- June 21, 2004
CopyrightCOPYRIGHT 2004 Knight-Ridder/Tribune Business News. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
By Ross Kerber, The Boston Globe Knight Ridder/Tribune Business News
Jun. 21--With a trial of Abiomed Inc.'s artificial heart nearing completion, the company's new chief executive is looking to get Wall Street's blood moving faster.
The Danvers cardiac-devices company is best-known for its AbioCor artificial heart, which is almost through a clinical trial the company needs before it can start selling the device more widely -- it hopes by early next year.
But chief executive Michael R. Minogue has begun outlining new ambitions for the company's less-glamorous products, as well, external cardiac pumps that assist patients with weak hearts, ...